Literature DB >> 18641392

Asp330 and Tyr331 in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation.

Martijn Bruysters1, Miriam Verhoef-Post, Axel P N Themmen.   

Abstract

The luteinizing hormone (LH) receptor plays an essential role in male and female gonadal function. Together with the follicle-stimulating hormone (FSH) and thyroid stimulating hormone (TSH) receptors, the LH receptor forms the family of glycoprotein hormone receptors. All glycoprotein hormone receptors share a common modular topography, with an N-terminal extracellular ligand binding domain and a C-terminal seven-transmembrane transduction domain. The ligand binding domain consists of 9 leucine-rich repeats, flanked by N- and C-terminal cysteine-rich regions. Recently, crystal structures have been published of the extracellular domains of the FSH and TSH receptors. However, the C-terminal cysteine-rich region (CCR), also referred to as the "hinge region," was not included in these structures. Both structure and function of the CCR therefore remain unknown. In this study we set out to characterize important domains within the CCR of the LH receptor. First, we mutated all cysteines and combinations of cysteines in the CCR to identify the most probable disulfide bridges. Second, we exchanged large parts of the LH receptor CCR by its FSH receptor counterparts, and characterized the mutant receptors in transiently transfected HEK 293 cells. We zoomed in on important regions by focused exchange and deletion mutagenesis followed by alanine scanning. Mutations in the CCR specifically decreased the potencies of LH and hCG, because the potency of the low molecular weight agonist Org 41841 was unaffected. Using this unbiased approach, we identified Asp(330) and Tyr(331) as key amino acids in LH/hCG mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641392      PMCID: PMC2533784          DOI: 10.1074/jbc.M804395200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function.

Authors:  I T Huhtaniemi
Journal:  Endocr Rev       Date:  2000-10       Impact factor: 19.871

2.  Molecular basis of lutropin recognition by the mannose/GalNAc-4-SO4 receptor.

Authors:  D S Roseman; J U Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 3.  The leucine-rich repeat as a protein recognition motif.

Authors:  B Kobe; A V Kajava
Journal:  Curr Opin Struct Biol       Date:  2001-12       Impact factor: 6.809

4.  Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns.

Authors:  Susanna Moore; Holger Jaeschke; Gunnar Kleinau; Susanne Neumann; Stefano Costanzi; Jian-kang Jiang; John Childress; Bruce M Raaka; Anny Colson; Ralf Paschke; Gerd Krause; Craig J Thomas; Marvin C Gershengorn
Journal:  J Med Chem       Date:  2006-06-29       Impact factor: 7.446

5.  Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH.

Authors:  J Gromoll; U Eiholzer; E Nieschlag; M Simoni
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

6.  Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues.

Authors:  Marco Bonomi; Marta Busnelli; Luca Persani; Gilbert Vassart; Sabine Costagliola
Journal:  Mol Endocrinol       Date:  2006-08-10

7.  Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region.

Authors:  K Nakabayashi; M Kudo; B Kobilka; A J Hsueh
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Expression of an in vitro biologically active equine LH/CG without C-terminal peptide (CTP) and/or beta26-110 disulphide bridge.

Authors:  C Galet; M Chopineau; N Martinat; Y Combarnous; F Guillou
Journal:  J Endocrinol       Date:  2000-10       Impact factor: 4.286

Review 9.  Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases.

Authors:  N Matsushima; N Tachi; Y Kuroki; P Enkhbayar; M Osaki; M Kamiya; R H Kretsinger
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

10.  The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.

Authors:  Yumiko Mizutori; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Mol Endocrinol       Date:  2008-01-24
View more
  17 in total

Review 1.  The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

Authors:  David Puett; Krassimira Angelova; Marcelo Rocha da Costa; Susanne W Warrenfeltz; Francesca Fanelli
Journal:  Mol Cell Endocrinol       Date:  2010-05-02       Impact factor: 4.102

2.  Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor.

Authors:  Xuliang Jiang; Heli Liu; Xiaoyan Chen; Po-Han Chen; David Fischer; Venkataraman Sriraman; Henry N Yu; Steve Arkinstall; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

3.  Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist.

Authors:  Claire L Newton; Adele M Whay; Craig A McArdle; Meilin Zhang; Chris J van Koppen; Ruud van de Lagemaat; Deborah L Segaloff; Robert P Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

4.  Functional differences of invariant and highly conserved residues in the extracellular domain of the glycoprotein hormone receptors.

Authors:  Krassimira Angelova; Hugo de Jonge; Joke C M Granneman; David Puett; Jan Bogerd
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

5.  Research resource: novel structural insights bridge gaps in glycoprotein hormone receptor analyses.

Authors:  Annika Kreuchwig; Gunnar Kleinau; Gerd Krause
Journal:  Mol Endocrinol       Date:  2013-06-24

6.  Defining structural and functional dimensions of the extracellular thyrotropin receptor region.

Authors:  Gunnar Kleinau; Sandra Mueller; Holger Jaeschke; Paul Grzesik; Susanne Neumann; Anne Diehl; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

7.  The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.

Authors:  Sandra Mueller; Gunnar Kleinau; Mariusz W Szkudlinski; Holger Jaeschke; Gerd Krause; Ralf Paschke
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

8.  Functional characterization of a new human melanocortin-4 receptor homozygous mutation (N72K) that is associated with early-onset obesity.

Authors:  Patric J D Delhanty; Elise Bouw; Martin Huisman; Resie M L Vervenne; Axel P N Themmen; Aart Jan van der Lely; Erica L T van den Akker
Journal:  Mol Biol Rep       Date:  2014-08-28       Impact factor: 2.316

9.  Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors.

Authors:  Rongbin Guan; Xueqing Wu; Xiuyan Feng; Meilin Zhang; Terence E Hébert; Deborah L Segaloff
Journal:  Cell Signal       Date:  2009-09-30       Impact factor: 4.315

Review 10.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.